Halia Therapeutics Stock

Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.

Sign up today and learn more about Halia Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Halia Therapeutics Stock

Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.

Funding History

February 2021$5.0M
December 2022$12.2M
January 2024$30.0M

Management

Vice President Regulatory Affairs

Lisa Shamon

CEO

David J. Bearss

Senior Medical Director

Xianne Penny

Chief Operating Officer - Co-Founder

Jared Bearss

Chief Financial Officer

Jeff Burton

CEO, President and Chairman of the Board

David J. Bearss

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo